|
Cohort1: ICT biopsy_Tcm
|
| Administration route |
None |
| Dosage |
2E6 cells, 10E6 cells |
| Donor type |
Autologous |
| Pts |
2 |
| Age |
Child, Adult, Older_Adult |
| References |
PMID:
38454126
|
|
|
Cohort2: ICT resection_Tcm
|
| Administration route |
None |
| Dosage |
2E6 cells, 10E6 cells, 50E6 cells, 20E6 cells, 100E6 cells |
| Donor type |
Autologous |
| Pts |
18 |
| Age |
Child, Adult, Older_Adult |
| References |
PMID:
38454126
|
|
|
Cohort3: ICV_Tcm
|
| Administration route |
None |
| Dosage |
2E6 cells, 10E6 cells, 50E6 cells, 20E6 cells, 100E6 cells |
| Donor type |
Autologous |
| Pts |
11 |
| Age |
Child, Adult, Older_Adult |
| References |
PMID:
38454126
|
|
|
Cohort4: dual ICT/ICV_Tcm
|
| Administration route |
None |
| Dosage |
2E6 cells, 10E6 cells, 50E6 cells |
| Donor type |
Autologous |
| Pts |
12 |
| Age |
Child, Adult, Older_Adult |
| References |
PMID:
38454126
|
|
|
Cohort5: dual ICT/ICV_Tn/mem
|
| Administration route |
None |
| Dosage |
2E6 cells, 10E6 cells, 50E6 cells, 20E6 cells, 100E6 cells |
| Donor type |
Autologous |
| Pts |
22 |
| Age |
Child, Adult, Older_Adult |
| Outcome |
1/21(CR); 10/21(SD); 10/21(PD); Median overall survival:10.2 months |
| References |
PMID:
38454126
|
|